Nextgen Biomed Ltd (TLV:NXGN)

Israel · Delayed Price · Currency is ILS · Price in ILA

52.80

+2.60 (5.18%)

Jun 26, 2025, 11:15 AM IDT

Nextgen Biomed Income Statement

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Selling, General & Admin	3.87	4.45	3.13	2.49	1.33	Upgrade
Research & Development	0.74	0.8	0.46	0.35	-	Upgrade
Other Operating Expenses	0.26	-	-	-	-	Upgrade
Operating Expenses	4.88	5.25	3.58	2.84	1.33	Upgrade
Operating Income	-4.88	-5.25	-3.58	-2.84	-1.33	Upgrade
Interest Expense	-0.02	-0.03	-0.06	-0	-	Upgrade
Interest & Investment Income	-	-	0.1	0.15	0.01	Upgrade
Currency Exchange Gain (Loss)	-0	-0.01	0.02	-0.02	0.02	Upgrade
Other Non Operating Income (Expenses)	-	-7.36	0.69	0.16	-	Upgrade
EBT Excluding Unusual Items	-4.9	-12.65	-2.84	-2.55	-1.3	Upgrade
Gain (Loss) on Sale of Investments	0	-	-	-	-	Upgrade
Asset Writedown	-	-1.55	-5.74	-	-	Upgrade
Pretax Income	-4.9	-14.2	-8.58	-2.55	-1.3	Upgrade
Earnings From Continuing Operations	-4.9	-14.2	-8.58	-2.55	-1.3	Upgrade
Minority Interest in Earnings	0.01	0.01	0.01	0	0	Upgrade
Net Income	-4.89	-14.19	-8.57	-2.55	-1.3	Upgrade
Net Income to Common	-4.89	-14.19	-8.57	-2.55	-1.3	Upgrade
Shares Outstanding (Basic)	8	7	7	7	5	Upgrade
Shares Outstanding (Diluted)	8	7	7	7	5	Upgrade
Shares Change (YoY)	15.90%	0.53%	8.67%	22.66%	12.16%	Upgrade
EPS (Basic)	-0.58	-1.95	-1.19	-0.38	-0.24	Upgrade
EPS (Diluted)	-0.58	-1.95	-1.19	-0.38	-0.24	Upgrade
Free Cash Flow	-2.16	-4.44	-2.75	-2.66	-1.55	Upgrade
Free Cash Flow Per Share	-0.26	-0.61	-0.38	-0.40	-0.29	Upgrade
EBITDA	-4.78	-5.25	-3.57	-2.83	-1.33	Upgrade
D&A For EBITDA	0.09	0	0.01	0	0	Upgrade
EBIT	-4.88	-5.25	-3.58	-2.84	-1.33	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.